New hope for GI cancers: Review analyzes molecular targets and treatment advancements

FHS
June 18, 2024
3:05 pm

Gastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal carcinomas, represent a significant global health burden due to their high incidence and mortality rates.

56% of Americans Concerned About Contracting an Infectious Disease from a Hospital

What You Should Know: New survey findings released today by Kinnos show that the risk of becoming infected by visiting or staying in a hospital weighs heavily

November 9, 2023

Pharmaceutical Packaging Companies in Contract Manufacturing

Pharmaceutical packaging companies play a vital role in maintaining the quality, safety, user-friendliness and marketability of drugs and other pharmaceutical products. The pharmaceutical industry requires

September 24, 2024

Ideaya partners with Gilead; Lilly extends offer for Point; Theseus lets go of CEO, CMO

Ideaya and Gilead will study a potential combo in bladder cancer. The South San Francisco-based company announced Monday that it plans to test its MAT2A

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.